Senior Executive Marketing and General Management

VITO J. MANGIARDI, MBA

** **. ******** **.

San Rafael, CA 94903

415-***-**** public profile www.linkedin.com/pub/vito-mangiardi/2/140/546 ******@***.***

Profile

Accomplished CEO/COO with twenty-two years of P&L responsibility in the Life Sciences and Pharmaceutical service industries. Successful in building top-performing growth orientated National and International organizations. Background in Leadership, Strategic Marketing, Operations Management, Financial Planning and Technology Development. Reliable and decisive leader who served on the Board of Directors of three biotechnology companies. Significant achievements include:

Leadership:

As SVP/Group Executive for a division of a $1.8 billion company, increased sales by 60% to $240 million

in two years. Successful in hiring and developing dynamic teams in North America, Europe, Asia and South America.

Strategic Marketing:

As President of $100 million company, successfully established marketing strategy and achieved sales increase of 98%

and EBITDA increase of 20% in two years. As SVP/COO of a $40 million company, increased sales by 67% from

$55 million to $92 million and positioned the company to become market leader.

Operations Management:

As CEO of a $32 million company, integrated three acquired companies from North America, Europe and

Asia into a single organization and reduced costs by 16%.

Financial Management:

As CEO and COO in two different companies, developed and implemented a financial model and comprehensive capital and operating budgets that resulted in a record double digit efficiency increase.

Technology Development:

As Head of the Global Marketing Technology Development Group for a $300 million company, led the

development of technology and products that positioned the company as a market leader in Hematology and

Thyroid testing. Examples of products include Hemoglobin A1c, L-Thyroxine, Vitamin B12/Folic Acid, and Solid Phase Antibody Separation Technology.

Professional Experience

Marin Bay Partners, LLC March, 2011- Present

Founding Partner and Chief Executive Officer

Consulting Company focused on providing marketing and Clinical Trial Operational Know-How to the Life Sciences Industry focused on Biotechnology and Pharmaceutical Start–up, small and mid-level size companies. Initially founded as Viman, Inc. in October, 2004 and in 2011 re-activated as Marin Bay Partners, LLC.

Lawrence Berkeley National Laboratory Joint Genome Institute (JGI) October, 2008–March, 2011

A division of the Lawrence Berkeley National Laboratories (LBNL) managed by the University of California, Berkeley and funded by the Dept. of Energy (DOE).

CHIEF OPERATIONS OFFICER

Deputy Director, Business Operations & Production

Responsible for all operations including Genetic Sequencing, Analysis, Informatics, Finance, HR, IT, Public Affairs, Facilities, Procurement and Safety Departments. Manage total yearly budget of $70 million and 270 staff. Senior member of The Joint Management Board (JMB) and The Strategic Management Team (SMT) and Chair of the Operations Management Team.

Elevated the JGI to be globally recognized as an efficient high-throughput Genomic data generation and analysis organization.

Introduced cost effective programs to integrate technology into the workplace and improve efficiency in workflow process resulting in reduced cycle times from 300 days to 40 days.

Created value added programs that accelerated the movement of science from the laboratories of researchers to the science community around the world.

Developed, implemented and established an outstanding process management delivery culture that significantly improved client satisfaction.

Bilcare Ltd.

A $100 million provider of contract research and development services primarily in the Pharmaceutical and Biotechnology industries.

Bilcare GCS February, 2008- October, 2008

CHIEF EXECUTIVE OFFICER

Responsible for the global clinical and preclinical services and supplies business in North America, Europe, and Asia

Transformed Bilcare services from a regional business to a scalable integrated global business and positioned the company

as an international player with facilities in North America, Europe and India.

Built a dynamic global team that increased revenues by 35% and EBITDA by 22% .

Refocused the strategic marketing services from a small to a midsize and large pharma client base to ensure global project market share.

Positioned the company for a spin-off and established first steps for public offering.

AAIPharma, Inc November, 2004 –February, 2008

A $100 million provider of contract research and development services primarily in the Pharmaceutical and Biotechnology industries

PRESIDENT, NORTH AMERICA OPERATIONS

Responsible for Phase I-IV Clinical Development Services, Analytical, Bioanalytical and Non-Clinical business lines. Hired to lead the company out of bankruptcy and position it for sale. Developed planning and budgets to achieve expected results. Provided effective leadership to help lead the company out of bankruptcy and enhance the health and image of the organization to customers, board members and employees.

Increased sales by 98% from $44 million to $87 million, and increased EBITDA by 20% in two years.

Increased Net Revenue by 50% and positioned company for sale in 2008.

Provided leadership to 741 staff and a senior management team of 8.

Continuously improved technology, competencies, efficiencies, communication and project management, resulting in improved customer perception of the company, employees, and work environment.

Quintiles Transnational, Inc. August, 1994 – October, 2004

A $1.8 billion provider of contract research and development, sales, marketing and health economic services primarily in pharmaceutical and biotechnology.

SENIOR VICE PRESIDENT and CHIEF OPERATING OFFICER (2003 – 2004)

Head of Global Operations for the Strategic Research Services Business Unit (QSRS), Quintiles Transnational (QTRN). Responsible for all global operations for non-registration and consulting services. Chair of the QSRS Senior Operations Executive Team.

Expanded sales from $55 million to $92 million.

Directed the hiring of four international regional general managers and established the management teams.

Successfully positioned QSRS, as a $90 million dollar operation, to become the market leader resulting in a 5% increase in market shares.

SENIOR VICE PRESIDENT (March,2001- 2003)

Head of International Clinical Development Services for Quintiles Japan, China and Australia. Initiated key operating systems and implemented International project management and Operational processes to enhance and Optimize Clinical Trials outcomes.

Instrumental as member of the Executive Team to improve operating income from 2% to 14% within a 12-month period.

Assisted in client presentations and helped Business Development to increase net new business from $150 million to

$240 million.

Led the effort to establish collaborative service agreements in Brazil, Hawaii, and Peru related to ethnic Japanese studies.

Clingenix, Inc. March, 1999 – February, 2001

An early stage Pharmacogenomics company offering a full range of genomic based research services and diagnostic products for monitoring disease and disease progression primarily in the Pharmaceutical and Biotechnology industries.

PRESIDENT AND CHIEF EXECUTIVE OFFICER

Provided vision, leadership, and management know-how for the Clingenix start-up consisting of clinical development services and Pharmacogenomics discovery.

Raised $6 million to ensure the further expansion of Pharmacogenomics intellectual property and diagnostic products.

Instrumental in building an experienced management team and expanding staff from 6 to 87.

Responsible for 6 completed acquisitions and instrumental in developing 5 potential acquisitions.

Member of the Board of Directors.

Quintiles Transnational, Inc. August, 1994 –February, 1999

An $800 million provider of contract research and development, sales, marketing and health economic services primarily in the pharmaceutical and biotechnology industries.

EXECUTIVE VICE PRESIDENT – Operational Services, Quintiles Americas (1997 – 1999)

Led the Operational Services business unit consisting of 700 staff with core services in data management, biostatistics, clinical monitoring, drug safety, and clinical sciences. Responsible for ensuring “top” and “bottom” line performance goals consisting of

$86 million in net revenue and $19 million in operating income.

Produced a 35% increase in net revenue from $64 million to $86 million and a 73% increase in operating income from

$11 million to $19 million.

EXECUTIVE VICE PRESIDENT – Business Management, Quintiles Americas (1996 – 1997)

Directed a management team of 10 with oversight of Office Operational Clinical Laboratories, HR, IT, and Finance for the Americas.

Achieved 52% growth in net revenue and 55% growth in operating income for Quintiles Americas in 1996.

EXECUTIVE VICE PRESIDENT – Asia Pacific Region, Quintiles Pacific Inc. (1995- 1996)

Led a team of 9 consisting of 7 offices in Japan, Singapore, Australia and New Zealand, with net revenue of $30 million.

Produced 75% growth in net revenue and 80% growth in operating income for Quintiles Asia Pacific Region in 1996.

Achieved 144% of expectations in operating income and 100% in net revenue for Quintiles Pacific, Inc.

Clinical Trials Best Practices training to 6 MD’s from China on how to effectively conduct Clinical Trials and commence Clinical Trial Services Operations.

VICE PRESIDENT/GENERAL MANAGER – Quintiles Pacific Inc. (1994 – 1995)

Led the company to a successful commercialization of its services and on to industry leadership.

Achieved 283% growth in net revenue from $6 million to $17 million in 2 years. Increased operating income by 408% (from 6% to 24%) and net income by 550% (from 2% from 11%).

Diagnostic Laboratories, Inc. May, 1986 –July, 1994

A start- up company and provider of laboratory services to doctors, clinics and other health care providers. Led the growth of the company to two core laboratories, 8 stat labs, and 20 service centers.

PRESIDENT & CHIEF EXECUTIVE OFFICER (1992 - 1994)

Led a management team of 6 and reported to the Chairman of the Board of Directors. Chartered with generating substantial sales growth to position the company for sale.

Increased earnings per share from $6.00 to $44.00 and sold the company at a premium for cash.

VICE PRESIDENT/GENERAL MANAGER (1988 – 1992)

OPERATIONS MANAGER (1986 - 1988)

PREVIOUS POSITIONS

Baxter Travenol, Aug, 1981 – April, 1986

BioRad Laboratories, Inc., April, 1973 –July, 1981

Education

University of North Carolina

Executive Leadership Program 2003

Golden Gate University

MBA, General Management 1983

MBA, Marketing 1980

Eastern Illinois University

Bachelor of Science, Biology/Chemistry 1970

ADDENDUM

PATENTS & ABSTRACTS

Mangiardi, V.J., Jeong, H.J., and Lewin, N., Folate Assay with Ion Exchange Resin

Bound-Free Separation, United States Patent No. 4,135,880.

Willner, H. and Mangiardi, V.J., Methods for the Analysis of Thyroid Hormones, United States Patent No. 4,086,059.

Lewin, N. and Mangiardi, V.J., Competitive Binding Thyroid Assay with Improved Bound-Free Separation, United States Patent No. 4,015,939.

Highberg, R.G., and Mangiardi, V., A Correlation of Human Follicle Stimulating Hormone Radio-Immunoassay Kits from Three Manufactures, Abstracts of the annual meeting of the American Association of Clinical Chemistry; Boston, Massachusetts.

Grenholz, A., Wood, R., Rogers, P., and Mangiardi, V., Rapid Quantitative Determination of Hemoglobin A1 Using Ion-Exchange Chromatography, Abstracts of the annual meeting of the American Association of Clinical Chemistry; New Orleans, Louisiana.

Tsing, S., and Mangiardi, V., Rapid Quantitative Determination of Urinary 4- Hydroxy-3 Methoxymadelic Acid (VMA) Using Ion Exchange Chromatography, Abstracts of the annual meeting of the American Association of Clinical Chemistry; New Orleans, Louisiana.

Doetsch, K., and Mangiardi, V., and Lewin N., Effective Quality Control of Folate Radioassay, Abstracts of the annual meeting of the American Association of Clinical Chemistry; Chicago, Illinois.

PROFESSIONAL AFFILIATIONS

American Management Association (AMA)

American Association of Clinical Chemistry (AACC)

Biotechnology Industry Organization (BIO)

Drug Information Association (DIA)

Leadership Think Tank

Harvard Business Review

COO Network

Pharma Connections Worldwide

The Chief Executive Officer (TGL)

Partnerships with CROs

Professionals in the Pharmaceuticals and Biotech Industry

Contact this candidate